Cullinan Therapeutics, Inc. (CGEM) has a market capitalization of $868.55M and trades at $14.35. The 52-week range is 5.68-16.74.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.9, Earnings Per Share (EPS) of $-3.72.
The stock has a beta of -0.11, operates in the Healthcare sector.
